Article ID Journal Published Year Pages File Type
9170218 Journal of Cardiac Failure 2005 5 Pages PDF
Abstract
In aged-matched controls with no MSHD, spirometric variables (FEV1/FVC) explain 18% to 25% of the variance in pV˙O2, and 16% to 18% of the variance in patients with NYHA class I-II symptoms. As symptoms worsen, the influence of spirometric variables on peak exercise capacity diminishes, and there is no such relation in the NYHA class III-IV patients.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , ,